Change Agents Corporation refinances loan, adds $10M equity line

Change Agents Corporation, trading as CHGA on Nasdaq, disclosed two financing transactions in filings covering late July 2026.

On July 24, 2026, the company signed a Business Loan and Security Agreement with a commercial lender for a loan in the principal amount of $825,000, with net proceeds of $254,350 after an administration fee of $41,500 and repayment in full of a prior March 2026 loan of $529,400, with a total repayment amount of $1,188,000 including interest charges of $363,000, repayable in 30 weekly installments of $37,125 beginning July 29, 2026 and maturing March 3, 2027.¹ The loan is secured, and the company's wholly-owned subsidiaries Avalon Healthcare System Inc., Avalon Laboratory Services, Inc., and Avalon Quantum AI LLC guaranteed the Business Loan and the Secured Note.¹ The lender also agreed to a forbearance on the prior loan, and in exchange the company agreed to issue the lender 360,000 shares as Commitment Shares, along with piggyback registration rights.¹

Separately, on July 22, 2026, the company entered an Equity Purchase Agreement with Hudson Global Ventures, LLC, under which the company may require the investor to purchase common stock having an aggregate purchase price of up to $10,000,000 during a commitment period.² The purchase price for shares sold under the agreement is set at $0.30 per share.² Each draw, or "put," is subject to minimum and maximum size limits, and must be at least $15,000 and cannot exceed the lesser of $500,000 or 200% of average daily trading value.² Alongside the purchase agreement, the company issued Hudson Global Ventures a warrant, with the right to purchase up to 925,925 shares of common stock at an exercise price of $0.01 per share.² The company also agreed to file a resale registration statement covering the shares within specified deadlines under a related Registration Rights Agreement.